[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Trastuzumab Market Report 2016

December 2016 | 103 pages | ID: U1B2164E519EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Trastuzumab

Revenue, means the sales value of Trastuzumab

This report studies sales (consumption) of Trastuzumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Merck & Co.
  • Roche
  • Taiho Pharmaceutical
  • Sumitomo Dainippon Pharma
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Trastuzumab in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Trastuzumab Market Report 2016

1 TRASTUZUMAB OVERVIEW

1.1 Product Overview and Scope of Trastuzumab
1.2 Classification of Trastuzumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Trastuzumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Trastuzumab (2011-2021)
  1.4.1 United States Trastuzumab Sales and Growth Rate (2011-2021)
  1.4.2 United States Trastuzumab Revenue and Growth Rate (2011-2021)

2 UNITED STATES TRASTUZUMAB COMPETITION BY MANUFACTURERS

2.1 United States Trastuzumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Trastuzumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Trastuzumab Average Price by Manufactures (2015 and 2016)
2.4 Trastuzumab Market Competitive Situation and Trends
  2.4.1 Trastuzumab Market Concentration Rate
  2.4.2 Trastuzumab Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES TRASTUZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Trastuzumab Sales and Market Share by Type (2011-2016)
3.2 United States Trastuzumab Revenue and Market Share by Type (2011-2016)
3.3 United States Trastuzumab Price by Type (2011-2016)
3.4 United States Trastuzumab Sales Growth Rate by Type (2011-2016)

4 UNITED STATES TRASTUZUMAB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Trastuzumab Sales and Market Share by Application (2011-2016)
4.2 United States Trastuzumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES TRASTUZUMAB MANUFACTURERS PROFILES/ANALYSIS

5.1 Bristol-Myers Squibb
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Trastuzumab Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bristol-Myers Squibb Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Eli Lilly and Company
  5.2.2 Trastuzumab Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Eli Lilly and Company Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck & Co.
  5.3.2 Trastuzumab Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck & Co. Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Roche
  5.4.2 Trastuzumab Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Roche Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Taiho Pharmaceutical
  5.5.2 Trastuzumab Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Taiho Pharmaceutical Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sumitomo Dainippon Pharma
  5.6.2 Trastuzumab Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sumitomo Dainippon Pharma Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 TRASTUZUMAB MANUFACTURING COST ANALYSIS

6.1 Trastuzumab Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Trastuzumab

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Trastuzumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Trastuzumab Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES TRASTUZUMAB MARKET FORECAST (2016-2021)

10.1 United States Trastuzumab Sales, Revenue Forecast (2016-2021)
10.2 United States Trastuzumab Sales Forecast by Type (2016-2021)
10.3 United States Trastuzumab Sales Forecast by Application (2016-2021)
10.4 Trastuzumab Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Trastuzumab
Table Classification of Trastuzumab
Figure United States Sales Market Share of Trastuzumab by Type in 2015
Table Application of Trastuzumab
Figure United States Sales Market Share of Trastuzumab by Application in 2015
Figure United States Trastuzumab Sales and Growth Rate (2011-2021)
Figure United States Trastuzumab Revenue and Growth Rate (2011-2021)
Table United States Trastuzumab Sales of Key Manufacturers (2015 and 2016)
Table United States Trastuzumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Trastuzumab Sales Share by Manufacturers
Figure 2016 Trastuzumab Sales Share by Manufacturers
Table United States Trastuzumab Revenue by Manufacturers (2015 and 2016)
Table United States Trastuzumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Trastuzumab Revenue Share by Manufacturers
Table 2016 United States Trastuzumab Revenue Share by Manufacturers
Table United States Market Trastuzumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Trastuzumab Average Price of Key Manufacturers in 2015
Figure Trastuzumab Market Share of Top 3 Manufacturers
Figure Trastuzumab Market Share of Top 5 Manufacturers
Table United States Trastuzumab Sales by Type (2011-2016)
Table United States Trastuzumab Sales Share by Type (2011-2016)
Figure United States Trastuzumab Sales Market Share by Type in 2015
Table United States Trastuzumab Revenue and Market Share by Type (2011-2016)
Table United States Trastuzumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Trastuzumab by Type (2011-2016)
Table United States Trastuzumab Price by Type (2011-2016)
Figure United States Trastuzumab Sales Growth Rate by Type (2011-2016)
Table United States Trastuzumab Sales by Application (2011-2016)
Table United States Trastuzumab Sales Market Share by Application (2011-2016)
Figure United States Trastuzumab Sales Market Share by Application in 2015
Table United States Trastuzumab Sales Growth Rate by Application (2011-2016)
Figure United States Trastuzumab Sales Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Trastuzumab Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Trastuzumab Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Trastuzumab Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Trastuzumab Sales Market Share (2011-2016)
Table Taiho Pharmaceutical Basic Information List
Table Taiho Pharmaceutical Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiho Pharmaceutical Trastuzumab Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Trastuzumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Trastuzumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Trastuzumab
Figure Manufacturing Process Analysis of Trastuzumab
Figure Trastuzumab Industrial Chain Analysis
Table Raw Materials Sources of Trastuzumab Major Manufacturers in 2015
Table Major Buyers of Trastuzumab
Table Distributors/Traders List
Figure United States Trastuzumab Production and Growth Rate Forecast (2016-2021)
Figure United States Trastuzumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Trastuzumab Production Forecast by Type (2016-2021)
Table United States Trastuzumab Consumption Forecast by Application (2016-2021)


More Publications